A phase 3, open-label, multisite, randomized, parallel group study of the efficacy and safety of fixed combination torcetrapib/atorvastatin administered once daily compared to simvastatin for 6 weeks in subjects with hypercholesterolemia (A5091030)
Latest Information Update: 23 Jul 2007
At a glance
- Drugs Torcetrapib/atorvastatin (Primary) ; Simvastatin
- Indications Hypercholesterolaemia
- Focus Biomarker; Registrational; Therapeutic Use
- Sponsors Pfizer
- 05 Dec 2006 Status change
- 19 Aug 2006 New trial record.